✦ LIBER ✦

Evaluating Co-primary Endpoints Collectively in Clinical Trials

✍ Scribed by Qian H. Li

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 118 KB
Volume: 51
Category: Article
ISSN: 0323-3847
DOI: 10.1002/bimj.200710497

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluating multiple treatment courses in

Evaluating multiple treatment courses in clinical trials

✍ Peter F. Thall; Randall E. Millikan; Hsi-Guang Sung 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

In oncology, a patient's treatment often involves multiple courses of chemotherapy. The most common medical practice in choosing treatments for successive courses is to repeat a treatment that is successful in a given course and otherwise switch to a different treatment. Patient outcome thus consist

Quality of life as an endpoint in EORTC

Quality of life as an endpoint in EORTC clinical trials

✍ Gwendoline M. Kiebert; Desmond Curran; Neil K. Aaronson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

For more than 30 years the European Organization for Research and Treatment for Cancer (EORTC) has conducted, co-ordinated, and stimulated research on the experimental and clinical bases of treatment of cancer and related problems. For more than a decade the EORTC has included quality of life as an

Inference on Multiple Endpoints in Clini

Inference on Multiple Endpoints in Clinical Trials with Adaptive Interim Analyses

✍ Meinhard Kieser; Peter Bauer; Walter Lehmacher 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Superiority Inferences on Individual End

Superiority Inferences on Individual Endpoints Following Noninferiority Testing in Clinical Trials

✍ Brent R. Logan; Ajit C. Tamhane 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

Controlling alpha in a clinical trial: t

Controlling alpha in a clinical trial: the case for secondary endpoints

✍ Ralph B. D'Agostino Sr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

We have become masters of clinical trials. We design them beautifully, our protocols delineate objectives and categorize sharply e$cacy variables as primary or secondary, teams of investigators execute them e$ciently and then we analyse with the latest and most sophisticated statistical methods. Yet

Resampling-based methods for the analysi

Resampling-based methods for the analysis of multiple endpoints in clinical trials

✍ Peter Reitmeir; Gernot Wassmer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

We consider multivariate tests for comparing two treatments with multiple endpoints. The test decision is drawn from the simultaneous consideration of the univariate tests for the single endpoints. A general class of these tests, called cut-o! tests, can be given, which, however, can lead to highly